LOS ANGELES, March 6, 2012 /PRNewswire/ -- BG Medical
Technologies, Inc. (OTC:RIGH) today announces the relocation to new
corporate headquarters for accommodating its rapid growth and
future expansion plans. These new facilities will provide
increased capacity for medical marijuana laboratory testing,
developing natural medicine solutions, media production, content
creation, sales, and leadership functions across the company.
The newly designed laboratory is configured to work in tandem
with BudGenius software upgrades aimed at significantly increasing
labor efficiency across a network of integrated hardware. The new
laboratory will also support added technologies for increased data
collection. Dedicated media suites for educational video production
are being established, along with an HD post-production facility
for onsite video and audio editing. An expanded sales area has been
selected to house regional trainings, and also to support call
center growth through 2015.
"This new and creative space greatly increases our capabilities
and aligns us with our ongoing growth. We expected this to build
upon team synergies while providing our staff the resources to
rapidly develop new technologies for medical marijuana and natural
medicines," said Angel Stanz, Chief
Executive Officer for BG Medical Technologies. "Our team is excited
about the growth we are experiencing and this move represents our
commitment to building upon the successes our team has
accomplished."
Final property selection will be completed within the next 45
days, with several weeks planned for gradual relocation. Completed
facilities are expected to be fully operational by end of June.
About BG Medical Technologies
BG Medical Technologies develops ancillary support services for
medical cannabis patients and professionals, including its flagship
medical marijuana research laboratory and website portal,
BudGenius.com. BG Medical Technologies, Inc. currently trades under
the symbol OTC:RIGH. Symbol and name change pending.
http://www.BgMedTech.com
BG Medical Technologies and its companies do not sell, grow,
harvest, cultivate, nor distribute medical cannabis.
The foregoing press announcement contains forward-looking
statements that can be identified by such terminology such as
"believes," "expects," "potential," "plans," "suggests," "may,"
"should," "could," "intends," or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results
to be materially different from any future results, performance or
achievements expressed or implied by such statements. In
particular, management's expectations could be affected by, among
other things, uncertainties relating to our success in completing
acquisitions, financing our operations, entering into strategic
partnerships, engaging management and other matters disclosed by us
in our public filings from time to time. Forward-looking statements
speak only as to the date they are made. The Company does not
undertake to update forward-looking statements to reflect
circumstances or events that occur after the date the
forward-looking statements are made.
Contact:
Angel Stanz
Chief Executive Officer
pr(at)bgmedtech(dot)com
(855) 723-3283
SOURCE BG Medical Technologies, Inc.